Buch, Englisch, 120 Seiten, Format (B × H): 170 mm x 241 mm, Gewicht: 402 g
Reihe: Milestones in Drug Therapy
Buch, Englisch, 120 Seiten, Format (B × H): 170 mm x 241 mm, Gewicht: 402 g
Reihe: Milestones in Drug Therapy
ISBN: 978-3-7643-7138-8
Verlag: Springer
After three introductory chapters that deal with the general theme of obesity – now regarded as a chronic disease – this volume discusses the drugs sibutramine and orlistat, which are approved for long-term use in the US and in much of the rest of the world. The three final chapters discuss future drug targets, like the central nervous system and gut hormones, and how to influence energy expenditure and substrate utilization.
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
Why drugs?.- Some historical aspects of drug treatment for obesity.- Regulation of energy balance — towards rational drug design in obesity.- Intestinal lipase inhibitors.- Sibutramine.- The endocannabinoid system as a target for obesity treatment.- Using the body’s natural signals — gut hormones.- Influencing energy expenditure and substrate utilisation.
